Kenneth Cunningham, Director at Verona Pharma plc (VRNA), sold 13,112 shares at $0.84 ($11K) on 2021-05-04, disclosed to the SEC on 2021-05-05.
Scheduled sale ($11k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |